| Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence A Labastida-Ramírez, S Benemei, M Albanese, A D’Amico, G Grillo, ... The journal of headache and pain 21, 1-15, 2020 | 48 | 2020 |
| Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance S Sacco, C Lampl, A Maassen van den Brink, V Caponnetto, ... The Journal of Headache and Pain 22 (1), 39, 2021 | 41 | 2021 |
| Neurology training and research in the Covid‐19 pandemic: a survey of the Resident and Research Fellow Section of the European Academy of Neurology L Cuffaro, V Carvalho, G Di Liberto, L Klinglehoefer, A Sauerbier, ... European journal of neurology 28 (10), 3437-3442, 2021 | 20 | 2021 |
| Education research: Impact of burnout on neurology residents and research fellows in Europe G Di Liberto, G Baldizzi, V Carvalho, L Cuffaro, A Sauerbier, ... Neurology® Education 1 (2), e200035, 2022 | 7 | 2022 |
| Efficacy and safety of anti-CGRP (r) monoclonal antibodies in real clinical practice: preliminary analysis after three months of therapy NV Vashchenko, DZ Korobkova, KV Skorobogatykh, YE Azimova Neurology, Neuropsychiatry, Psychosomatics 13 (6), 62-66, 2021 | 5 | 2021 |
| Клиническая эффективность и безопасность анти-CGRP (r) моноклональных антител в реальной клинической практике после трех месяцев терапии НВ Ващенко, ДЗ Коробкова, КВ Скоробогатых, ЮЭ Азимова Неврология, нейропсихиатрия, психосоматика 13 (6), 62-66, 2021 | 3 | 2021 |
| Нарушения сна при мигрени НВ Ващенко, АИ Кожев, ЮЭ Азимова Медицинский совет, 99-108, 2021 | 3 | 2021 |
| Дополнительные методы лечения при острой неспецифической люмбалгии ОА Солоха, НВ Ващенко Неврология, нейропсихиатрия, психосоматика 11 (S1), 98-102, 2019 | 2 | 2019 |
| Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies N Vashchenko, K Skorobogatykh, J Azimova, D Korobkova CEPHALALGIA 41 (1_ SUPPL), 182-182, 2021 | 1 | 2021 |
| Off-label use of CGRP monoclonal antibodies in patients with chronic cluster headache N Vashchenko, Y Azimova, D Korobkova, K Skorobogatykh EUROPEAN JOURNAL OF NEUROLOGY 28, 706-706, 2021 | 1 | 2021 |
| Sleep disorders improvement after the 12-week mindfulness therapy sessions in myofascial facial pain syndrome patients G Shevtsova, L Medvedeva, O Zagorulko, N Vashchenko European Journal of Neurology, Supplement 27 (S1), 1227-1227, 2020 | 1 | 2020 |
| Nervous system injury in alcoholic disease OE Zinovyeva, NV Vashchenko, OE Mozgovaya, TA Yanakaeva, ... Neurology, Neuropsychiatry, Psychosomatics 11 (2S), 83-88, 2019 | 1 | 2019 |
| Enhancing Prophylaxis: Erenumab to Fremanezumab Transition in Migraine N Vashchenko, A Uzhakhov, D Korobkova, J Azimova, K Skorobogatykh CEPHALALGIA 43 (1 supp), 261-261, 2023 | | 2023 |
| Influence of significant stressful events on the course of primary cephalalgia. YE Azimova, KV Skorobogatykh, VV Osipova, ML Kukushkin, ... Russian Journal of Pain, 26-32, 2023 | | 2023 |
| Prospective evaluation of migraine premonitory symptoms during the 30 days period K Skorobogatykh, J Azimova, D Korobkova, N Vashchenko, A Uzhakhov, ... JOURNAL OF HEADACHE AND PAIN 23 (SUPPL 1), 2022 | | 2022 |
| Real-World fremanezumab experience from headache clinic in Moscow J Azimova, K Skorobogatykh, A Uzhakhov, N Vashchenko, M Kukushkin, ... JOURNAL OF HEADACHE AND PAIN 23 (SUPPL 1), 2022 | | 2022 |
| Cluster headache patients' phenotypes according to their verapamil response A Uzhakhov, N Vashchenko, D Korobkova, K Skorobogatykh, J Azimova EUROPEAN JOURNAL OF NEUROLOGY 29, 590-590, 2022 | | 2022 |
| Fremanezumab in the cluster headache treatment. A Uzhakhov, N Vashchenko, D Korobkova, K Skorobogatykh, J Azimova EUROPEAN JOURNAL OF NEUROLOGY 29, 590-590, 2022 | | 2022 |
| CGRP plasma levels in migraine patients before and after CGRP monoclonal antibodies therapy N Vashchenko, A Uzhakhov, M Bogorodskaya, D Korobkova, J Azimova, ... EUROPEAN JOURNAL OF NEUROLOGY 29, 86-86, 2022 | | 2022 |
| Предикторы эффективности применения эренумаба при хронической мигрени НВ Ващенко Consilium Medicum 24 (2), 104-107, 2022 | | 2022 |
Kirill SkorobogatykhUniversity Headache Clinic, Moscow, RussiaVerified email at headache.ru
